In vitro, it has been shown that Novobiocin (coumermycin antibiotic) enhances the sensitivity of breast cancer cells to Topotecan by overcoming the breast cancer resistance protein (BCRP)-mediated drug resistance [41]. The gene discussed is ABCG2; the disease is breast cancer.